PRESS RELEASE published on 04/19/2023 at 21:00, 3 years 4 months ago Abivax reports 2022 financial results and operations update
PRESS RELEASE published on 04/19/2023 at 21:00, 3 years 4 months ago Abivax : résultats annuels 2022 et point d’avancement sur l’activité
PRESS RELEASE published on 04/18/2023 at 18:00, 3 years 4 months ago Abivax appoints Michael Ferguson as Chief Commerical Officer
PRESS RELEASE published on 04/18/2023 at 18:00, 3 years 4 months ago Michael Ferguson est nommé Directeur Commercial d’Abivax
PRESS RELEASE published on 04/17/2023 at 18:00, 3 years 4 months ago Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis
PRESS RELEASE published on 04/17/2023 at 18:00, 3 years 4 months ago Abivax annonce les résultats d’efficacité et de tolérance d’obefazimod après deux ans de traitement dans l’étude de maintenance de phase 2b dans la rectocolite hémorragique
PRESS RELEASE published on 04/05/2023 at 19:30, 3 years 5 months ago Marc de Garidel est nommé Directeur Général et Président par intérim du Conseil d’Administration d’Abivax
PRESS RELEASE published on 04/05/2023 at 19:30, 3 years 5 months ago Abivax appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
PRESS RELEASE published on 03/29/2023 at 18:00, 3 years 5 months ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 28.02.23.
PRESS RELEASE published on 03/16/2023 at 18:30, 3 years 5 months ago Abivax adjusts its 2023 Financial Communication Calendar
Published on 09/12/2026 at 02:35, 8 hours 14 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 11 hours 49 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 12 hours 44 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 13 hours 24 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 17 hours 49 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 3 hours 18 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 12 hours 34 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 12 hours 38 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 15 hours 4 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 16 hours 33 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 3 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 3 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 15 hours ago Availability of the 2026 Interim Financial Report
